![]() |
Name |
Cochlioquinone D
|
Molecular Formula | C28H38O6 | |
IUPAC Name* |
(3R,4aR,6aR,12aR,12bR)-3-(2-hydroxypropan-2-yl)-6a,12b-dimethyl-9-[(E,2S)-4-methyl-3-oxohex-4-en-2-yl]-1,2,3,4a,5,6,12,12a-octahydropyrano[3,2-a]xanthene-8,11-dione
|
|
SMILES |
C/C=C(\C)/C(=O)[C@@H](C)C1=CC(=O)C2=C(C1=O)O[C@@]3(CC[C@@H]4[C@@]([C@H]3C2)(CC[C@@H](O4)C(C)(C)O)C)C
|
|
InChI |
InChI=1S/C28H38O6/c1-8-15(2)23(30)16(3)17-13-19(29)18-14-20-27(6)11-9-21(26(4,5)32)33-22(27)10-12-28(20,7)34-25(18)24(17)31/h8,13,16,20-22,32H,9-12,14H2,1-7H3/b15-8+/t16-,20+,21+,22+,27+,28+/m0/s1
|
|
InChIKey |
WVAGHYJGMXPWJS-FDCOXKCVSA-N
|
|
Synonyms |
COCHLIOQUINONE D; CHEMBL2288171
|
|
CAS | NA | |
PubChem CID | 76316514 | |
ChEMBL ID | CHEMBL2288171 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 470.6 | ALogp: | 3.7 |
HBD: | 1 | HBA: | 6 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 89.9 | Aromatic Rings: | 4 |
Heavy Atoms: | 34 | QED Weighted: | 0.463 |
Caco-2 Permeability: | -4.67 | MDCK Permeability: | 0.00002110 |
Pgp-inhibitor: | 0.078 | Pgp-substrate: | 0.003 |
Human Intestinal Absorption (HIA): | 0.009 | 20% Bioavailability (F20%): | 0.008 |
30% Bioavailability (F30%): | 0.003 |
Blood-Brain-Barrier Penetration (BBB): | 0.069 | Plasma Protein Binding (PPB): | 98.03% |
Volume Distribution (VD): | 0.761 | Fu: | 3.61% |
CYP1A2-inhibitor: | 0.378 | CYP1A2-substrate: | 0.846 |
CYP2C19-inhibitor: | 0.128 | CYP2C19-substrate: | 0.569 |
CYP2C9-inhibitor: | 0.438 | CYP2C9-substrate: | 0.271 |
CYP2D6-inhibitor: | 0.794 | CYP2D6-substrate: | 0.15 |
CYP3A4-inhibitor: | 0.392 | CYP3A4-substrate: | 0.401 |
Clearance (CL): | 2.783 | Half-life (T1/2): | 0.489 |
hERG Blockers: | 0.214 | Human Hepatotoxicity (H-HT): | 0.503 |
Drug-inuced Liver Injury (DILI): | 0.037 | AMES Toxicity: | 0.016 |
Rat Oral Acute Toxicity: | 0.299 | Maximum Recommended Daily Dose: | 0.922 |
Skin Sensitization: | 0.875 | Carcinogencity: | 0.042 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.326 |
Respiratory Toxicity: | 0.534 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002924 | ![]() |
0.786 | D0W5LS | ![]() |
0.272 | ||
ENC003638 | ![]() |
0.784 | D0G8BV | ![]() |
0.260 | ||
ENC004572 | ![]() |
0.776 | D04ATM | ![]() |
0.260 | ||
ENC002182 | ![]() |
0.776 | D0W2EK | ![]() |
0.259 | ||
ENC003007 | ![]() |
0.614 | D0EP0C | ![]() |
0.255 | ||
ENC001862 | ![]() |
0.600 | D04GJN | ![]() |
0.252 | ||
ENC002674 | ![]() |
0.600 | D07BSQ | ![]() |
0.250 | ||
ENC005795 | ![]() |
0.586 | D0Q4SD | ![]() |
0.250 | ||
ENC000943 | ![]() |
0.548 | D0F1UL | ![]() |
0.250 | ||
ENC004573 | ![]() |
0.528 | D0X4RS | ![]() |
0.250 |